From: Telemedicine for the management of diabetic patients in a high-complexity Latin American hospital
Type 1 Diabetes | First Teleconsultation | Last Teleconsultation | p-value | n |
---|---|---|---|---|
Glycosylated hemoglobin, %* | ||||
< 6 months | 8.3 (6.9–10) | 7.7 (7-10.1) | 0.363 | 15 |
≥ 6 months | 7.7 (7.12–8.5) | 7.5 (7-8.5) | 0.345 | 42 |
LDL cholesterol, mg/dL* | ||||
< 6 months | 97 (74–120) | 97 (87–107) | 1 | 2 |
≥ 6 months | 74 (58–89) | 72 (61–77) | 0.964 | 11 |
HDL cholesterol, mg/dL* | ||||
< 6 months | 46.5 (39–54) | 56.5 (54–59) | 0.180 | 2 |
≥ 6 months | 66 (59–76) | 63.5 (50–70) | 0.240 | 10 |
Triglycerides, mg/dL* | ||||
< 6 months | 114 (108–120) | 78 (60–96) | 0.180 | 2 |
≥ 6 months | 88 (57–106) | 90 (65–135) | 0.197 | 11 |
Creatinine, mg/dL* | ||||
< 6 months | 1 (0.64–1.08) | 0.93 (0.73–1.13) | 0.500 | 5 |
≥ 6 months | 0.765 (0.675-0.9) | 0.8 (0.735–0.875) | 0.724 | 12 |
Microalbuminuria, mg/L* | ||||
< 6 months | 24.75 (17.5–32) | 12 (12–12) | 0.180 | 2 |
≥ 6 months | 4.85 (2.55–14.5) | 4.8 (4.4-14.05) | 0.854 | 4 |